Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 06-2018 | 03-2018 | |
| Operating Expenses | 0 | 199 | 0 | 0 | 198 |
| Operating Income | N/A | -199 | N/A | N/A | -198 |
| Interest Expense | 0 | 0 | 0 | 0 | 6 |
| Other Income | 0 | 4,073 | 0 | 0 | 1,079 |
| Pre-tax Income | 0 | 3,874 | 0 | 0 | 875 |
| Net Income Continuous | N/A | 3,874 | N/A | N/A | 875 |
| Net Income | $N/A | $3,874 | $N/A | $N/A | $875 |
| EPS Basic Total Ops | N/A | 3.20 | N/A | N/A | 0.80 |
| EPS Basic Continuous Ops | N/A | 3.01 | N/A | N/A | 0.68 |
| EPS Diluted Total Ops | N/A | 3.20 | N/A | N/A | 0.80 |
| EPS Diluted Continuous Ops | N/A | 3.01 | N/A | N/A | 0.68 |
| EBITDA(a) | $N/A | $-199 | $N/A | $N/A | $-198 |